Journey Medical Corp (DERM)

$4.27

+0.26

(+6.48%)▲

Live

Insights on Journey Medical Corp

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 34.53M → 13.03M (in $), with an average decrease of 35.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 16.78M → -10.44M (in $), with an average decrease of 250.0% per quarter

Performance

  • $3.91
    $4.32
    $4.27
    downward going graph

    8.54%

    Downside

    Day's Volatility :9.49%

    Upside

    1.04%

    downward going graph
  • $1.25
    $8.11
    $4.27
    downward going graph

    70.73%

    Downside

    52 Weeks Volatility :84.59%

    Upside

    47.35%

    downward going graph

Returns

PeriodJourney Medical CorpIndex (Russel 2000)
3 Months
0.25%
0.0%
6 Months
-19.32%
0.0%
1 Year
178.47%
0.0%
3 Years
-57.79%
-22.6%

Highlights

Market Capitalization
78.1M
Book Value
$0.65
Earnings Per Share (EPS)
-0.17
Wall Street Target Price
7.83
Profit Margin
-5.2%
Operating Margin TTM
-77.44%
Return On Assets TTM
0.42%
Return On Equity TTM
-40.69%
Revenue TTM
80.0M
Revenue Per Share TTM
4.27
Quarterly Revenue Growth YOY
6.7%
Gross Profit TTM
42.9M
EBITDA
4.1M
Diluted Eps TTM
-0.17
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.93
EPS Estimate Next Year
-0.24
EPS Estimate Current Quarter
-0.23
EPS Estimate Next Quarter
-0.19

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Journey Medical Corp(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 83.37%

Current $4.27
Target $7.83

Technicals Summary

Sell

Neutral

Buy

Journey Medical Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Journey Medical Corp
Journey Medical Corp
12.96%
-19.32%
178.47%
-57.79%
-57.25%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
-1.26%
20.07%
49.07%
48.24%
66.16%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
2.79%
0.0%
2.67%
14.3%
14.3%
Zoetis Inc.
Zoetis Inc.
3.87%
-5.35%
0.73%
-1.62%
59.42%
Viatris Inc.
Viatris Inc.
-10.49%
9.3%
13.4%
-31.25%
-35.25%
Catalent, Inc.
Catalent, Inc.
-3.71%
35.8%
43.6%
-46.34%
16.03%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Journey Medical Corp
Journey Medical Corp
NA
NA
NA
-0.93
-0.41
0.0
NA
0.65
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
36.8
36.8
0.44
4.07
0.18
0.1
NA
23.72
Haleon Plc Spon Ads
Haleon Plc Spon Ads
28.13
28.13
1.69
0.46
0.07
0.04
0.03
1.8
Zoetis Inc.
Zoetis Inc.
32.67
32.67
2.58
5.77
0.5
0.14
0.01
11.07
Viatris Inc.
Viatris Inc.
224.4
NA
NA
2.74
0.0
0.03
0.05
16.81
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.06
0.25
-0.28
-0.01
NA
19.96
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Journey Medical Corp
Journey Medical Corp
Buy
$78.1M
-57.25%
NA
-5.2%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$13.6B
66.16%
36.8
18.65%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$38.5B
14.3%
28.13
9.64%
Zoetis Inc.
Zoetis Inc.
Buy
$77.4B
59.42%
32.67
27.38%
Viatris Inc.
Viatris Inc.
Hold
$12.6B
-35.25%
224.4
-0.37%
Catalent, Inc.
Catalent, Inc.
Hold
$9.7B
16.03%
211.02
-28.44%

Institutional Holdings

  • Vanguard Group Inc

    1.55%

  • Renaissance Technologies Corp

    1.30%

  • Acadian Asset Management LLC

    1.11%

  • American Financial Group Inc

    0.90%

  • TANG CAPITAL MANAGEMENT LLC

    0.69%

  • Walleye Trading Advisors, LLC

    0.67%

Company Information

Organization
Journey Medical Corp
Employees
41
CEO
Dr. Lindsay Allan Rosenwald
Industry
Health Technology

Discover More

FAQs